翻訳と辞書 |
Acceleron Pharma : ウィキペディア英語版 | Acceleron Pharma
Acceleron Pharma, Inc. is a public American "clinical stage biopharmaceutical company" based in Boston, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels. ==History== John Knopf, Jasbir Seehra, Tom Maniatis, Mark Ptashne and Wylie Vale formed the company in Cambridge, Massachusetts.〔〔 The company began with a venture capital investment and opened its first laboratory in December 2003.〔 〔http://files.shareholder.com/downloads/AMDA-23MZWJ/552975461x7981394x690792/4DD0FFF0-C9CC-4E40-8310-E252D74ABBFC/BioCentury-Emerging-Co-Acceleron.pdf〕 The company tendered an initial public offering in September 2013.〔
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Acceleron Pharma」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|